Modules
- Module 1 – Pharmacogenomics Primer
- Module 2 – Clinical Applications of Pharmacogenomics in Cardiology
- Module 3 – Clinical Applications of Pharmacogenomics in Psychiatry an Pain Management
- Module 4 – Education and Training in Clinical Pharmacogenomics
- Module 5 – Oncology, Adverse Drug Reactions and Electrionic Health Records
- Module 6 – Clinical Implementations
Module 1 – Pharmacogenomics Primer
- View the Module 1 slides and videos below:
Principles of Genetic Medicine Part I
Principles of Genetic Medicine Part 2
Pharmacogenetics of Drug Metabolism Part 1
Pharmacogenetics of Drug Metabolism Part 2
Pharmacogenetics of Drug Metabolism Part 3
Pharmacogenetics of Drug Metabolism Part 4
Pharmacogenetics of Drug Metabolism Part 5
2. Complete the Module 1 post test, achieving a score of 27 or above. Your score will be instantly provided after you submit your exam. If you do not achieve a score of 27 or above please contact the Office of Continuing Pharmacy Education.
3. Complete the course evaluation.
Program Details
- Intended Audience: Pharmacists
- UAN: 0012-0000-17-258-H04-P
- CE Hours: 2.75 General
- Price: $55.00
- Dates Available: 10/03/2017-10/03/2020
- Activity Type: Knowledge
Summary
This course will summarize the principles of drug metabolism pharmacogenetics and genetic medicine.
Objectives:
- Pharmacogenetics of Drug Metabolism: Parts 1-5
- Summarize scientific principles of pharmacogenomics, including discussion of:
- Human genetics.
- Relationship between genotypes and phenotypes in the context of pharmacogenomics.
- Types of polymorphisms, including single nucleotide polymorphisms.
- Linkage disequilibrium.
- Haplotypes and diplotypes.
- Star-allele nomenclature.
- Discuss the different types of studies in the pharmacogenomics literature and their corresponding levels of evidence.
- Explain the contribution of pharmacokinetics and genetics to interindividual variability in response.
- Discuss relevant genetic polymorphisms of important drug metabolizing enzymes and their potential clinical implications.
- Explain the function and tissue distribution of drug transporters.
- Discuss variations in drug transporters and their clinical significance
- Compare pharmacogenetics and therapeutic drug monitoring (TDM)
- List example drugs for which pharmacogenetics-guided TDM may be the most useful
Principles of Genetic Medicine: Parts I-2
- Review DNA.
- Explain the Human Genome Project.
- Discuss the Central Dogma of Molecular Biology.
- Discuss the Types of polymorphisms.
- Define allele, genotype, and phenotype
- Define linkage disequilibrium, haplotype, and diplotype
- Introduce PharmGKB
- Summarize scientific principles of pharmacogenomics, including discussion of:
Speakers, Acknowledgements, and Disclosures
The following speakers have disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
Caitrin W. McDonough, Ph.D.
Research Assistant Professor
Department of Pharmacotherapy and Translational Research
College of Pharmacy, University of Florida
Reginald F. Frye, Pharm.D., Ph.D., FCCP
Professor and Chair
Department of Pharmacotherapy and Translational Research
College of Pharmacy, University of Florida
Schedule of Activities
Review all course materials and pass post-test with 70% or more.
Requirements for Successful Course Completion
View recorded lectures, receive a 70% or higher on final exam and complete course evaluation.
Credit Reporting
- The University of Florida College of Pharmacy will report CPE credit to CPE Monitor and CE Broker when applicable. If you would like a paper statement of credit, you may print it from your NABP e-profile.
- All pharmacists and pharmacy technicians maintain their own license and/or certification and it is their responsibility to follow up with the Office of Continuing Education at the University of Florida if any CE credit discrepancies are found.
- It is at the University’s discretion to award or deny credit to a late claiming participant (i.e. after 60 days of the participant engaging in a CPE activity) as it is the University’s CE activity and the provider needs to ensure the requirements necessary for credit are successfully completed.
- The University may request access to CPE Monitor® if the activity in question occurred within the previous 6 months and with an appropriate reason for access, i.e. power outage, etc.
Program Financial Support
This course received no outside funding support.
Computer Requirements
Computer and Internet access are required to complete this course. Course content is provided via Canvas.
The minimum hardware, software, and Internet requirements for Canvas can be found here.
Policies
Privacy and Confidentiality Policy
Copyright
This course in its entirety is copyrighted by the University of Florida Continuing Pharmacy Education and may not be duplicated or reproduced for any other purpose without specific written permission.
For questions or more information, please contact our office.
The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.